Diphtheria disease and azithromycin: PGD template
Patient Group Direction (PGD) for the supply of azithromycin for the prevention of diphtheria in high risk settings or during outbreaks.
Applies to England
Documents
Details
This PGD supports the supply or administration of azithromycin to adults and children aged 1 year and older with potential exposure to diphtheria in high risk settings or during outbreaks.
PGD version 02.00 is valid from 21 November 2022 to 20 November 2024.
The PGD template requires further authorisation by a clinical governance or patient safety lead who has designated responsibility for signing PGDs. It is not legal or valid without this local, formal authorisation.
The authorising commissioning body and providers are responsible for the adoption and governance of use of this PGD. Provider organisations and health professionals should check they are using the current version and only work to a legally authorised PGD from their commissioning body.
For further information see the supplementary guidance for cases and outbreaks in asylum seeker accommodation settings and the diphtheria document collection for other resources.
Updates to this page
Published 11 November 2022Last updated 22 November 2022 + show all updates
-
Added version 02.00.
-
First published.